MELANOMA AND OTHER MALIGNANT NEOPLASMS OF SKIN
Clinical trials for MELANOMA AND OTHER MALIGNANT NEOPLASMS OF SKIN explained in plain language.
Never miss a new study
Get alerted when new MELANOMA AND OTHER MALIGNANT NEOPLASMS OF SKIN trials appear
Sign up with your email to follow new studies for MELANOMA AND OTHER MALIGNANT NEOPLASMS OF SKIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Drug attack on Tough-to-Treat skin cancer
Disease control OngoingThis study is testing whether adding an experimental pill (GSK2636771) to an existing immunotherapy (pembrolizumab) can help control advanced melanoma that has not responded to prior treatments. It is specifically for patients whose cancer has a specific genetic change called PTE…
Matched conditions: MELANOMA AND OTHER MALIGNANT NEOPLASMS OF SKIN
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New combo aims to boost immune attack on tough melanoma
Disease control OngoingThis study is testing whether adding an oral drug called azacitidine to the immunotherapy pembrolizumab can help control advanced melanoma. It is for patients who are new to this type of immunotherapy or whose cancer has worsened despite it. The main goal is to see if the combina…
Matched conditions: MELANOMA AND OTHER MALIGNANT NEOPLASMS OF SKIN
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 03, 2026 14:07 UTC